Health Canada drug identification number

DIN 02547562 — ICATIBANT INJECTION 10 MG

ICATIBANT INJECTION is a solution of Icatibant marketed by JAMP PHARMA CORPORATION. The full Icatibant monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02547562
Brand name
ICATIBANT INJECTION
Active ingredient
Icatibant
Strength
10 MG
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
JAMP PHARMA CORPORATION
Health Canada status
MARKETED
Drug class
Bradykinin B2 receptor antagonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Icatibant products

DINBrandStrengthFormManufacturerStatus
02425696 FIRAZYR 10 MG SOLUTION TAKEDA CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.